ATE425964T1 - Cyclische amidinderivate - Google Patents

Cyclische amidinderivate

Info

Publication number
ATE425964T1
ATE425964T1 AT02720534T AT02720534T ATE425964T1 AT E425964 T1 ATE425964 T1 AT E425964T1 AT 02720534 T AT02720534 T AT 02720534T AT 02720534 T AT02720534 T AT 02720534T AT E425964 T1 ATE425964 T1 AT E425964T1
Authority
AT
Austria
Prior art keywords
isoindol
diethoxy
imino
fluoro
tert
Prior art date
Application number
AT02720534T
Other languages
English (en)
Inventor
Shuichi Suzuki
Makoto Kotake
Mitsuaki Miyamoto
Tetsuya Kawahara
Akiharu Kajiwara
Ieharu Hishinuma
Kazuo Okano
Syuhei Miyazawa
Richard Clark
Fumihiro Ozaki
Nobuaki Sato
Masanobu Shinoda
Atsushi Kamada
Itaru Tsukada
Fumiyoshi Matsuura
Yoshimitsu Naoe
Taro Terauchi
Yoshiaki Oohashi
Osamu Ito
Hiroshi Tanaka
Takashi Musha
Motoji Kogushi
Tsutomu Kawata
Toshiyuki Matsuoka
Hiroko Kuramochi
Ken-Ichi Chiba
Akifumi Kimura
Naoto Ono
Original Assignee
Eisai R&D Man Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai R&D Man Co Ltd filed Critical Eisai R&D Man Co Ltd
Application granted granted Critical
Publication of ATE425964T1 publication Critical patent/ATE425964T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pulmonology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrrole Compounds (AREA)
  • Indole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT02720534T 2001-04-19 2002-04-19 Cyclische amidinderivate ATE425964T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001121829 2001-04-19
JP2001269422 2001-09-05

Publications (1)

Publication Number Publication Date
ATE425964T1 true ATE425964T1 (de) 2009-04-15

Family

ID=26613890

Family Applications (3)

Application Number Title Priority Date Filing Date
AT02720534T ATE425964T1 (de) 2001-04-19 2002-04-19 Cyclische amidinderivate
AT02724628T ATE534627T1 (de) 2001-04-19 2002-04-19 2-iminopyrrolidin-derivate
AT05022069T ATE538090T1 (de) 2001-04-19 2002-04-19 Verfahren zur herstellung von 2-iminopyrrolidin- derivaten

Family Applications After (2)

Application Number Title Priority Date Filing Date
AT02724628T ATE534627T1 (de) 2001-04-19 2002-04-19 2-iminopyrrolidin-derivate
AT05022069T ATE538090T1 (de) 2001-04-19 2002-04-19 Verfahren zur herstellung von 2-iminopyrrolidin- derivaten

Country Status (21)

Country Link
US (6) US7476688B2 (de)
EP (6) EP1394152A4 (de)
JP (6) JP4445201B2 (de)
KR (2) KR100749795B1 (de)
CN (3) CN100402499C (de)
AT (3) ATE425964T1 (de)
AU (1) AU2005202135B2 (de)
BR (1) BR0208985A (de)
CA (1) CA2446924C (de)
CZ (1) CZ303865B6 (de)
DE (2) DE60233043D1 (de)
ES (1) ES2462995T3 (de)
HU (1) HUP0400467A3 (de)
IL (2) IL158491A0 (de)
MX (1) MXPA03009497A (de)
NO (1) NO327849B1 (de)
NZ (1) NZ528820A (de)
PL (1) PL368109A1 (de)
RU (1) RU2270192C2 (de)
WO (4) WO2002088092A1 (de)
ZA (1) ZA200308064B (de)

Families Citing this family (99)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6346510B1 (en) 1995-10-23 2002-02-12 The Children's Medical Center Corporation Therapeutic antiangiogenic endostatin compositions
US7235567B2 (en) 2000-06-15 2007-06-26 Schering Corporation Crystalline polymorph of a bisulfate salt of a thrombin receptor antagonist
IL158484A0 (en) 2001-04-18 2004-05-12 Euro Celtique Sa Nociceptin analogs
DE60233043D1 (de) * 2001-04-19 2009-09-03 Eisai R&D Man Co Ltd 2-iminoimidazolderivate
US8048917B2 (en) 2005-04-06 2011-11-01 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US7232924B2 (en) 2001-06-11 2007-06-19 Xenoport, Inc. Methods for synthesis of acyloxyalkyl derivatives of GABA analogs
US7186855B2 (en) 2001-06-11 2007-03-06 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US6818787B2 (en) 2001-06-11 2004-11-16 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US7049333B2 (en) * 2002-06-04 2006-05-23 Sanofi-Aventis Deutschland Gmbh Substituted thiophenes: compositions, processes of making, and uses in disease treatment and diagnosis
AU2003252259A1 (en) * 2002-07-26 2004-02-16 Nihon Nohyaku Co., Ltd. Novel haloalkylsulfonanilide derivatives, herbicides and usage thereof
AU2004218187C1 (en) * 2003-02-19 2011-04-07 Eisai R&D Management Co., Ltd. Methods for producing cyclic benzamidine derivatives
JP4786147B2 (ja) * 2003-06-26 2011-10-05 武田薬品工業株式会社 カンナビノイド受容体調節剤
US20070243632A1 (en) * 2003-07-08 2007-10-18 Coller Barry S Methods for measuring platelet reactivity of patients that have received drug eluting stents
ATE536889T1 (de) * 2003-07-08 2011-12-15 Accumetrics Inc Kontrollierte thrombozyten-aktivierung zur überwachung der behandlung von adp-antagonisten
CA2540061A1 (en) * 2003-09-30 2005-04-14 Merck & Co., Inc. Phenyl pyrrolidine ether tachykinin receptor antagonists
EP1677783A2 (de) 2003-10-08 2006-07-12 Nicholas Piramal India Limited Fibrinogen-rezeptor-antagonisten und ihre verwendung
RU2346935C2 (ru) * 2003-11-28 2009-02-20 Санкио Компани, Лимитед Производное циклического амина, содержащее гетероарильный цикл
JP4749702B2 (ja) * 2003-11-28 2011-08-17 第一三共株式会社 ヘテロアリール環を有する環状アミン誘導体
US7301036B2 (en) * 2003-12-19 2007-11-27 Merck & Co., Inc. Cyclic guanidines, compositions containing such compounds and methods of use
WO2005084679A1 (ja) * 2004-03-04 2005-09-15 Eisai R & D Management Co., Ltd. ベンズアミジン誘導体含有組成物及びベンズアミジン誘導体の安定化方法
EP1751150A2 (de) * 2004-05-19 2007-02-14 Neurosearch A/S Neue azabicyclische arylderivate
CA2576952A1 (en) * 2004-08-16 2006-02-23 Eisai R & D Management Co., Ltd. Methods for producing isoindole derivatives
CN101068762B (zh) * 2004-08-17 2010-05-05 卫材R&D管理有限公司 制备二溴氟苯衍生物的方法
WO2006023844A2 (en) * 2004-08-20 2006-03-02 Entremed, Inc. Compositions and methods comprising proteinase activated receptor antagonists
EP1810965A4 (de) * 2004-10-13 2009-10-28 Eisai R&D Man Co Ltd Hydrazidderivate
JP2007084440A (ja) * 2004-11-09 2007-04-05 Eisai R & D Management Co Ltd トロンビン受容体アンタゴニストを有効成分とするくも膜下出血に伴う血管攣縮の治療剤
WO2006051648A1 (ja) * 2004-11-09 2006-05-18 Eisai R & D Management Co., Ltd. トロンビン受容体アンタゴニストを有効成分とするくも膜下出血に伴う血管攣縮の治療剤
JPWO2006051623A1 (ja) * 2004-11-09 2008-05-29 エーザイ株式会社 トロンビン受容体アンタゴニストを有効成分とするくも膜下出血に伴う血管攣縮の治療剤
DE102004061748A1 (de) * 2004-12-22 2006-07-06 Bayer Healthcare Ag Azetidin-substituierte Pyrazoline
DE102004061750A1 (de) * 2004-12-22 2006-07-06 Bayer Healthcare Ag Heteroaryl-substituierte Pyrazoline
US7786330B2 (en) 2005-02-28 2010-08-31 Asahi Glass Company, Limited Process for producing 1,2-dialkoxy-3-fluorobenzene
CN100366595C (zh) * 2005-02-28 2008-02-06 北京金源化学集团有限公司 一种经由中间体2-氟-6-卤代苯酚制备1,2-二烷氧基-3-氟苯的方法
WO2008023438A1 (en) 2006-08-25 2008-02-28 Asahi Glass Co., Ltd. Process for producing 1,2-dialkoxy-3-fluorobenzene
EP1867331A4 (de) 2005-04-06 2009-04-08 Takeda Pharmaceutical Triazol-derivat und seine verwendung
US7595169B2 (en) * 2005-04-27 2009-09-29 Accumetrics, Inc. Method for determining percent platelet aggregation
US20090306059A1 (en) * 2005-05-13 2009-12-10 Tomio Kimura Cyclic amine derivative having substituted alkyl group
JP2007001974A (ja) * 2005-05-27 2007-01-11 Sankyo Co Ltd ヘテロアリール環を有する環状アミン誘導体を含有する医薬組成物
EP2308852A1 (de) 2005-08-21 2011-04-13 Abbott GmbH & Co. KG 5-Ring-Heteroaromaten-Verbindungen und ihre Verwendung als Bindungspartner für 5-HT5-Rezeptoren
ES2530398T3 (es) * 2005-09-15 2015-03-02 Ucb Pharma Sa Pirrolidin-2-onas 4-sustituidas y su uso
CN101371545A (zh) * 2006-01-12 2009-02-18 诺基亚公司 通信系统中的导频加扰
CA2637674A1 (en) * 2006-01-19 2007-07-26 Abbott Laboratories 2-imino-benzimidazoles
WO2007102563A1 (ja) * 2006-03-02 2007-09-13 Eisai R & D Management Co., Ltd. 炎症性マーカー測定によるトロンビン受容体アンタゴニストの効果の判定方法
ATE557010T1 (de) * 2006-03-24 2012-05-15 Eisai R&D Man Co Ltd Triazolonderivat
TWI367112B (en) 2006-06-30 2012-07-01 Schering Corp Immediate-release tablet formulations of a thrombin receptor antagonist
DE102006036023A1 (de) * 2006-08-02 2008-02-07 Sanofi-Aventis Imino-imidazo-pyridinderivate mit antithrombotischer Aktivität
JPWO2008026527A1 (ja) * 2006-08-28 2010-01-21 株式会社カネカ ３−シアノピロリジン誘導体およびその塩の製造方法
GB2446652A (en) * 2007-02-16 2008-08-20 Inion Ltd Osteogenic compounds
US20090022729A1 (en) * 2007-04-13 2009-01-22 Nigel Mackman Methods and compositions for treating cardiac dysfunctions
KR20100017576A (ko) * 2007-05-03 2010-02-16 아큐메트릭스, 인크. 트롬빈 수용체 길항제에 의한 혈소판 응집 억제의 측정 방법
TWI417100B (zh) * 2007-06-07 2013-12-01 Astrazeneca Ab 二唑衍生物及其作為代謝型麩胺酸受體增效劑-８４２之用途
EP2202231A4 (de) * 2007-09-21 2011-09-28 Eisai R&D Man Co Ltd 2,3-dihydroiminoisoindolderivate
KR20100114018A (ko) * 2007-11-30 2010-10-22 바이엘 쉐링 파마 악티엔게젤샤프트 헤테로아릴-치환된 피페리딘
CA2711612A1 (en) 2008-01-11 2009-07-16 Eisai R&D Management Co., Ltd. Pharmaceutical composition, use of 2-iminopyrrolidine derivative for production of pharmaceutical composition, and kit for treatment or amelioration of heart diseases
JP5526040B2 (ja) 2008-02-05 2014-06-18 サノフイ Ｐａｒ１阻害剤としてのトリアゾロピリダジン類、その製造法および薬剤としての使用
EP2242740B1 (de) 2008-02-05 2012-12-12 Sanofi Sf5-derivate als par1-inhibitoren, ihre herstellung und verwendung als arzneimittel
CA2713551C (en) * 2008-02-05 2016-06-14 Sanofi-Aventis Triazolium salts as par1 inhibitors, production thereof, and use as medicaments
ES2603302T3 (es) * 2008-02-05 2017-02-24 Sanofi Imidazopiridazinas como inhibidores de PAR1, su obtención y empleo como medicamento
EP2268620A4 (de) * 2008-03-27 2011-08-10 Burnham Inst Medical Research Inhibitoren der antigenrezeptorinduzierten aktivierung von nf-kappa-b
US20100056519A1 (en) * 2008-07-15 2010-03-04 Serebruany Victor L Composition and method for reducing platelet activation and for the treatment of thrombotic events
MX2011006000A (es) 2008-12-08 2011-07-20 Boehringer Ingelheim Int Compuestos para tratar cancer.
WO2011015381A1 (en) * 2009-08-05 2011-02-10 Celltrend Gmbh Method for prognosis of pulmonary arterial hypertension by detecting anti-par1-antibodies
ES2528948T3 (es) 2009-09-21 2015-02-13 Chemocentryx, Inc. Derivados de pirrolidinona carboxamida como moduladores de quemerina-R (ChemR23)
US8673890B2 (en) * 2009-10-29 2014-03-18 Janssen Pharmaceutica Nv 2,3-dihydro-1H-isoindol-1-imine derivatives useful as thrombin PAR-1 receptor antagonist
ES2527535T3 (es) 2010-04-16 2015-01-26 Sanofi Piridil-vinil-pirazolo-quinolinas como inhibidores de PAR1
PL2558465T3 (pl) 2010-04-16 2015-05-29 Sanofi Sa Trycykliczne pirydylo-winylo-pirole jako inhibitory receptora aktywowanego proteazą 1 (PAR1)
CN102241621A (zh) * 2010-05-11 2011-11-16 江苏恒瑞医药股份有限公司 5,5-双取代-2-亚氨基吡咯烷类衍生物、其制备方法及其在医药上的应用
WO2012014889A1 (ja) * 2010-07-29 2012-02-02 エーザイ・アール・アンド・ディー・マネジメント株式会社 フタロニトリル誘導体の製造方法
CN102442965B (zh) * 2010-09-30 2013-12-11 天津药物研究院 用于治疗血栓性疾病的par-1拮抗剂及其制备方法和用途
CN102757396B (zh) * 2011-04-28 2014-10-15 天津药物研究院 含苯并五元杂环的环外亚胺化合物、其制备方法和用途
EA037918B1 (ru) 2011-12-21 2021-06-07 Новира Терапьютикс, Инк. Противовирусные агенты против гепатита в
WO2014046125A1 (ja) * 2012-09-20 2014-03-27 エーザイ・アール・アンド・ディー・マネジメント株式会社 トロンビン受容体アンタゴニストを有効成分とする肺高血圧症の予防治療剤
DK2961732T3 (en) 2013-02-28 2017-07-10 Janssen Sciences Ireland Uc SULFAMOYLARYLAMIDS AND USE THEREOF AS MEDICINES TO TREAT HEPATITIS B
JO3603B1 (ar) 2013-05-17 2020-07-05 Janssen Sciences Ireland Uc مشتقات سلفامويل بيرولاميد واستخدامها كادوية لمعالجة التهاب الكبد نوع بي
RS57999B1 (sr) 2013-05-17 2019-01-31 Janssen Sciences Ireland Uc Derivati sulfamoiltiofenamida i njihova primena kao lekovi za tretman hepatitisa b
UY35750A (es) 2013-09-26 2015-04-30 Mnemosyne Pharmaceuticals Inc Moduladores octahidro-ciclopenta[c] pirrol negativos de nr2b
SI3102576T1 (sl) 2014-02-03 2019-08-30 Vitae Pharmaceuticals, Llc Inhibitorji dihidropirolopiridina ROR-gama
CN104086501B (zh) * 2014-07-23 2016-02-17 张远强 一种par-1拮抗剂、其制备方法和用途
BR112017007460A2 (pt) 2014-10-14 2017-12-19 Vitae Pharmaceuticals Inc inibidores de di-hidropirrolopiridina de ror-gama
US9845308B2 (en) 2014-11-05 2017-12-19 Vitae Pharmaceuticals, Inc. Isoindoline inhibitors of ROR-gamma
US9663515B2 (en) 2014-11-05 2017-05-30 Vitae Pharmaceuticals, Inc. Dihydropyrrolopyridine inhibitors of ROR-gamma
WO2016085224A2 (en) * 2014-11-25 2016-06-02 Institute For Basic Science N-heterocyclic carbene nitric oxide radical and application thereof
KR101657054B1 (ko) 2014-11-25 2016-09-19 기초과학연구원 N-헤테로고리 카벤 일산화질소 라디칼 화합물 및 그 응용
WO2016114386A1 (ja) * 2015-01-15 2016-07-21 国立研究開発法人国立精神・神経医療研究センター 進行型免疫性脱髄疾患治療剤
ES2856931T3 (es) 2015-08-05 2021-09-28 Vitae Pharmaceuticals Llc Moduladores de ROR-gamma
WO2017087608A1 (en) 2015-11-20 2017-05-26 Vitae Pharmaceuticals, Inc. Modulators of ror-gamma
TWI757266B (zh) 2016-01-29 2022-03-11 美商維它藥物有限責任公司 ＲＯＲ－γ調節劑
EP3442524A2 (de) 2016-04-15 2019-02-20 Novira Therapeutics Inc. Kombinationen und verfahren mit einem kapsid-anordnungsinhibitor
US9481674B1 (en) 2016-06-10 2016-11-01 Vitae Pharmaceuticals, Inc. Dihydropyrrolopyridine inhibitors of ROR-gamma
WO2019018975A1 (en) 2017-07-24 2019-01-31 Vitae Pharmaceuticals, Inc. INHIBITORS OF ROR GAMMA
KR20200053481A (ko) 2017-07-24 2020-05-18 비타이 파마슈티컬즈, 엘엘씨 RORγ의 억제제
US10844044B2 (en) 2018-06-14 2020-11-24 Vanderbilt University WDR5 inhibitors and modulators
CN109053546B (zh) * 2018-07-05 2021-04-27 中国科学院兰州化学物理研究所 一种苯酞类衍生物及其制备方法和应用
US10807959B2 (en) 2018-08-16 2020-10-20 Vanderbilt University WDR5-MLL1 inhibitors and modulators
WO2022051384A1 (en) * 2020-09-01 2022-03-10 Albert Einstein College Of Medicine Compounds and methods for inhibition of bax-mediated cell death
KR102517368B1 (ko) * 2020-09-03 2023-03-31 경희대학교 산학협력단 항진균 활성을 갖는 신규한 이미다졸 유도체의 염 및 이의 용도
CN114181088B (zh) * 2021-12-21 2024-05-17 大连大学 一种离子液体[TEA][TfOH]2催化制备α-卤代苯乙酮类化合物的方法
KR102782945B1 (ko) * 2022-05-24 2025-03-18 주식회사 이노보테라퓨틱스 벤조퓨라닐 히드록시페닐 메타논 옥심 유도체 및 이의 용도
CN115521266A (zh) * 2022-10-25 2022-12-27 广东医科大学 一种乙烯基异噁唑烷衍生物的制备方法
CN116675677B (zh) * 2023-08-02 2023-09-26 中国林业科学研究院林产化学工业研究所 一种c8漆酚衍生物及其制备方法和应用

Family Cites Families (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR8129E (fr) 1906-03-09 1908-01-20 Zeiss Carl Soc Garniture de canon munie d'une lunette de visée
US6087380A (en) 1949-11-24 2000-07-11 Boehringer Ingelheim Pharma Kg Disubstituted bicyclic heterocycles, the preparations and the use thereof as pharmaceutical compositions
JPS4842875B1 (de) * 1969-01-29 1973-12-14
US3717648A (en) * 1970-10-21 1973-02-20 Sterling Drug Inc 1-phenyl-azacarbocyclic-2-imines
DE2154525A1 (de) 1970-11-05 1972-06-15 Carlo Erba S.P.A., Mailand (Italien) Isoindolinderivate und Verfahren zu ihrer Herstellung
US4118504A (en) 1970-11-05 1978-10-03 Carlo Erba Isoindoline derivatives for treating pain
GB1344663A (en) 1970-11-10 1974-01-23 Erba Carlo Spa Isoindoline compounds
ZA722407B (en) 1971-05-13 1973-01-31 Richardson Merrell Inc Substituted cycloalkyl lactamimides
JPS512868B2 (de) 1971-09-30 1976-01-29
US3773788A (en) * 1971-11-26 1973-11-20 Standard Oil Co Method for the preparation of n-(substituted phenyl)-2-iminopyrrolidines
US3920688A (en) * 1973-02-05 1975-11-18 Monsanto Co 2-imino derivatives of substituted imidazoles
US3859302A (en) 1973-02-05 1975-01-07 Monsanto Co Preparation of 2-imino-imidazole derivatives
US3904395A (en) 1973-02-05 1975-09-09 Monsanto Co 2-Imino derivatives of substituted imidazoles
US3887577A (en) 1973-07-05 1975-06-03 Monsanto Co Process for the preparation of 2-imino derivatives of substituted imidazoles
US4153235A (en) * 1973-08-09 1979-05-08 Richardson-Merrell Inc. Substituted cycloalkyl lactamimides
DE2430354A1 (de) 1974-06-25 1976-01-15 Basf Ag Neue substituierte 1-amino-isoindole, verfahren zu deren herstellung sowie diese enthaltende pharmazeutische zubereitungen
JPS5122720A (ja) 1974-08-19 1976-02-23 Sumitomo Chemical Co Jukyobaifuanteigatadofutaroshianinganryono seizoho
GB1476949A (en) 1974-11-20 1977-06-16 Wyeth John & Brother Ltd Imidazo-1,2-a-benzimidazole and pyrimido-1,2-a-benzimidazole derivatives their preparation and their pharmaceutical compositions
GB1484615A (en) * 1974-11-23 1977-09-01 Lepetit Spa Tricyclic n-containing derivatives
US4004016A (en) * 1975-08-11 1977-01-18 E. R. Squibb & Sons, Inc. Amino-benzimidazole derivatives
JPS5371063A (en) 1976-12-03 1978-06-24 Grelan Pharmaceut Co Ltd Preparation of 4-(1-9x9-2-isoindolinyl)acetophenone
US4521793A (en) 1982-02-27 1985-06-04 Asahi Kasei Kogyo Kabushiki Kaisha Coloring method and color-forming material
JPS6222760A (ja) 1985-07-24 1987-01-30 Sankyo Co Ltd イソインドリン誘導体及びそれを有効成分とする農園芸用殺菌剤
US5002941A (en) 1985-12-12 1991-03-26 Smithkline Beecham Corporation Pyrrolo(1,2-a)imidazole and imidazo(1,2-a)pyridine derivatives and their use as 5-lipoxygenase pathway inhibitors
FR2595521B1 (fr) * 1986-03-07 1988-10-21 Electricite De France Dispositif de telecomptage
ES2005450A6 (es) 1987-11-16 1989-03-01 Gema Sa Procedimiento para la preparacion de derivados n(4-etil-2,3-dioxo)-piperacin-1-iln-carbonilo.
JP2805867B2 (ja) 1989-07-19 1998-09-30 日本電気株式会社 電子写真感光体
US5145818A (en) * 1989-12-29 1992-09-08 Mitsui Petrochemical Industries, Ltd. Olefin polymerization catalyst and process for the polymerization of olefins
CA2048003A1 (en) 1990-08-21 1992-02-22 Serge Burner Tricyclic pyridone derivatives
US5258387A (en) * 1990-08-21 1993-11-02 Hoffmann-La Roche Inc. Tricyclic pyridone derivatives
WO1992012590A1 (en) * 1991-01-03 1992-07-23 Sasktel Data collection network apparatus and method
EP0509582B1 (de) * 1991-04-16 1996-09-04 Koninklijke Philips Electronics N.V. SMD-Widerstand
DE69429641T2 (de) 1993-02-26 2002-08-29 Otsuka Pharmaceutical Co., Ltd. Thiazole oder imidazole derivate als maillard reaktion inhibitoren
JPH0732103A (ja) 1993-07-19 1995-02-03 Sumitomo Metal Ind Ltd 溶融金属の鋳造用ノズル
CN1077886C (zh) 1993-10-21 2002-01-16 G·D·瑟尔公司 用作一氧化一氮合酶抑制剂的脒基衍生物
CA2196271C (en) 1994-08-12 2007-01-09 Toyama Chemical Co., Ltd. Quinolone- or naphthyridonecarboxylic acid derivative or salt thereof
US5629322A (en) 1994-11-15 1997-05-13 Merck & Co., Inc. Cyclic amidine analogs as inhibitors of nitric oxide synthase
JP3666922B2 (ja) 1995-02-21 2005-06-29 山本化成株式会社 カルボン酸塩、その製造方法および該塩化合物を用いる感熱記録材料
TW401408B (en) 1995-07-21 2000-08-11 Fujisawa Pharmaceutical Co Heterocyclic compounds having prostaglandin I2 agonism
AU3440597A (en) 1996-07-02 1998-01-21 Novartis Ag N-phenylimino heterocyclic derivatives and their use as herbicides
JP2707239B2 (ja) * 1996-07-26 1998-01-28 日本バイエルアグロケム株式会社 シアノアルキルーヘテロ環式化合物及び殺虫剤
RU2180902C2 (ru) 1996-10-02 2002-03-27 Жансен Фармасетика Н.В. Производные 2-цианоиминоимидазола, ингибирующие pde iv, способы их получения, фармацевтическая композиция на их основе, способ ее получения
US5977134A (en) * 1996-12-05 1999-11-02 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
FR2757053B1 (fr) 1996-12-12 1999-01-22 Oreal Utilisation de derives de la di-imino-isoindoline ou de la 3-amino-isoindolone pour la teinture des fibres keratiniques et compositions de teinture les renfermant
PE121699A1 (es) 1997-02-18 1999-12-08 Boehringer Ingelheim Pharma Heterociclos biciclicos disustituidos como inhibidores de la trombina
US6187799B1 (en) 1997-05-23 2001-02-13 Onyx Pharmaceuticals Inhibition of raf kinase activity using aryl ureas
AU8270698A (en) * 1997-06-26 1999-01-19 Eli Lilly And Company Antithrombotic agents
US6465484B1 (en) * 1997-09-26 2002-10-15 Merck & Co., Inc. Angiogenesis inhibitors
NZ504218A (en) 1997-11-25 2002-04-26 Schering Corp Thrombin receptor antagonists
US6114532A (en) 1998-02-03 2000-09-05 Boehringer Ingelheim Pharma Kg Bicyclic heterocycles, the preparation thereof, and their use as pharmaceuticals
AU2720199A (en) * 1998-02-03 1999-08-23 Boehringer Ingelheim Pharma Kg Five-membered, benzo-condensed heterocycles used as antithrombotic agents
US6194447B1 (en) 1998-07-02 2001-02-27 Neurosearch A/S Bis (benzimidazole) derivatives serving as potassium blocking agents
ATE292120T1 (de) 1998-07-02 2005-04-15 Neurosearch As Kaliumkanal-blockierende mittel
WO2000053582A1 (fr) 1999-03-05 2000-09-14 Suntory Limited COMPOSES HETEROCYCLIQUES POSSEDANT UN EFFET D'ACTIVATION DU RECEPTEUR α4β2 DE L'ACETYLCHOLINE NICOTINIQUE
US6376530B1 (en) 1999-05-10 2002-04-23 Merck & Co., Inc. Cyclic amidines useful as NMDA NR2B antagonists
JP3647338B2 (ja) * 1999-11-11 2005-05-11 富士通株式会社 画像信号解像度変換方法及び装置
IL154928A0 (en) * 2000-11-10 2003-10-31 Lilly Co Eli 3-substituted oxindole beta 3 agonists
JP2002155060A (ja) 2000-11-15 2002-05-28 Japan Tobacco Inc イミダゾール化合物及びその用途
DE60233043D1 (de) * 2001-04-19 2009-09-03 Eisai R&D Man Co Ltd 2-iminoimidazolderivate
JP4151310B2 (ja) 2001-05-22 2008-09-17 Ｄｉｃ株式会社 硬化性不飽和樹脂組成物
US6726177B2 (en) * 2002-07-02 2004-04-27 Value Valves Co., Ltd. Valve with improved junk ring structure
JP3725843B2 (ja) 2002-07-05 2005-12-14 ローム株式会社 反射型センサ
AU2004218187C1 (en) 2003-02-19 2011-04-07 Eisai R&D Management Co., Ltd. Methods for producing cyclic benzamidine derivatives

Also Published As

Publication number Publication date
HUP0400467A3 (en) 2012-08-28
US7476688B2 (en) 2009-01-13
AU2002255269B2 (en) 2007-03-15
DE60231608D1 (de) 2009-04-30
NO327849B1 (no) 2009-10-05
IL158491A0 (en) 2004-05-12
HK1086269A1 (zh) 2006-09-15
JPWO2002088092A1 (ja) 2004-08-12
EP1391456A1 (de) 2004-02-25
NO20034632D0 (no) 2003-10-16
US20040254376A1 (en) 2004-12-16
CN1243735C (zh) 2006-03-01
AU2005202135B2 (en) 2007-11-15
WO2002085855A1 (fr) 2002-10-31
KR20050059343A (ko) 2005-06-17
EP1614680B1 (de) 2011-12-21
JPWO2002085850A1 (ja) 2004-08-12
EP1394152A4 (de) 2005-02-02
WO2002088092A1 (fr) 2002-11-07
BR0208985A (pt) 2004-03-09
JPWO2002085855A1 (ja) 2004-08-12
EP1386912A4 (de) 2006-02-01
JPWO2002088094A1 (ja) 2004-08-12
RU2270192C2 (ru) 2006-02-20
US7304083B2 (en) 2007-12-04
PL368109A1 (en) 2005-03-21
WO2002085850A1 (en) 2002-10-31
WO2002088094A1 (fr) 2002-11-07
EP1614680A2 (de) 2006-01-11
JP3795458B2 (ja) 2006-07-12
JP4516922B2 (ja) 2010-08-04
CZ20032824A3 (en) 2004-04-14
EP1614680A3 (de) 2006-02-01
CN1503784A (zh) 2004-06-09
JP4464928B2 (ja) 2010-05-19
ATE534627T1 (de) 2011-12-15
NO20034632L (no) 2003-12-19
CN1321996C (zh) 2007-06-20
US20050004204A1 (en) 2005-01-06
HUP0400467A2 (hu) 2005-02-28
EP1391456A4 (de) 2006-02-01
AU2005202135A1 (en) 2005-06-09
CZ303865B6 (cs) 2013-05-29
EP1391456B1 (de) 2009-07-22
JP4220249B2 (ja) 2009-02-04
ZA200308064B (en) 2005-04-26
ES2462995T3 (es) 2014-05-27
EP2385039A1 (de) 2011-11-09
KR100749794B1 (ko) 2007-08-17
EP1391451A4 (de) 2006-02-01
JP2006206595A (ja) 2006-08-10
CN1733725A (zh) 2006-02-15
EP1386912A1 (de) 2004-02-04
CN100402499C (zh) 2008-07-16
NZ528820A (en) 2007-01-26
JP4445201B2 (ja) 2010-04-07
EP1391451A1 (de) 2004-02-25
EP1391451B1 (de) 2011-11-23
US20050245592A1 (en) 2005-11-03
RU2003133664A (ru) 2005-05-10
JP2006225393A (ja) 2006-08-31
IL158491A (en) 2010-12-30
US20090215795A1 (en) 2009-08-27
EP1386912B1 (de) 2009-03-18
US20040242627A1 (en) 2004-12-02
EP2385039B1 (de) 2014-03-12
CA2446924C (en) 2011-02-08
KR20030090764A (ko) 2003-11-28
JP4251872B2 (ja) 2009-04-08
DE60233043D1 (de) 2009-09-03
US7244730B2 (en) 2007-07-17
CN1754880A (zh) 2006-04-05
MXPA03009497A (es) 2004-05-24
CA2446924A1 (en) 2002-10-31
ATE538090T1 (de) 2012-01-15
EP1394152A1 (de) 2004-03-03
KR100749795B1 (ko) 2007-08-17
US20050004197A1 (en) 2005-01-06

Similar Documents

Publication Publication Date Title
ATE425964T1 (de) Cyclische amidinderivate
NO307884B1 (no) Substituerte pyrazoler som CRF antagonister
EA199900953A1 (ru) ЗАМЕЩЕННЫЕ ПИРАЗОЛЫ, КАК ИНГИБИТОРЫ p38 КИНАЗЫ
DE59401924D1 (de) Substituierte heterocyclische Carbonsäureamide, ihre Herstellung und ihre Verwendung als Arzneimittel
DE68907921D1 (de) Substituierte pyrrol-, pyrazol- und triazol-angiotensin ii-antagonisten.
EA200100554A1 (ru) Замещенные пиразолы как ингибиторы p38 киназы
PT778277E (pt) Derivados heterociclicos substituidos como antagonistas do crf
DK0646115T3 (da) Heterocykliske/cykliske aminderivater
HRP20080226T3 (en) Quinoline and quinazoline derivatives having affinity for 5ht1-type receptors
DK0957099T3 (da) Heterocykliske carboxamider
PT866059E (pt) Novos derivados heterociclicos e sua utilizacao medicina
DE69723104D1 (de) Piridin-2-yl-methylamin-derivate, verfahren zu deren herstellung und ihre verwendung als arzneimittel
NO982222L (no) 3-(4-Subst.-piperidinyl-1)-1-(3,4-diklorfenyl)propylkarbamater og -ureaer og derivater som neurokinin-antagonister
FI956279L (fi) Menetelmiä ja välituotteita 5-/2-(4-(bentsoisotiatsol-3-yyli)piperatsin-1-yyli)etyyli/-6-kloori-1,3-dihydroindol-2-onin valmistamiseksi
ATE87919T1 (de) Mittel gegen angst.
DE69722031T2 (de) 4- (thien-3-yl)methyl] imidazolderivate mit alpha2-adrenoceptor agonistischer aktivität
HUT77174A (hu) Heterociklusos csoporttal szubsztituált 3-(indol-3-il)-akrilsav-származékok, mint NMDA antagonisták, és a vegyületeket tartalmazó gyógyszerkészítmények
DE50008094D1 (de) Tetramsäure-Derivate zur Verwendung in Medizin und Lebensmitteltechnologie
DK0687257T3 (da) 4-amino-2-(hetero)aryl-butanamider anvendelige som 5HT1A-antagonister
DE69632206D1 (de) (2-piperidin-1-yl-4-substituierte)-4-amino-2-chinazolin-derivate mit antihypertensiver wirkung, verfahren zu ihrer herstellung und ihrem pharmazeutischen gebrauch
DE50001742D1 (de) Arylsulfonamid-substituierte benzimidazolderivate und ihre verwendung als tryptase-inhibitoren
ATE388710T1 (de) Phthalazinderivate als phosphodiesterase-4-hemmer

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties